Topics

Articles

Do you need to hire a hub service for your Patient Access Strategy or can you get by with a good specialty pharmacy

Patient access strategy: specialty pharmacy, hub—or both?

Morris & Dickson publishes a family and company history

Since 1841: The Story of an Enduring Family Business

Specialty drug market access reality check

Enough already with REMS abuse in generic drug development

The keys to a successful and impactful partnership: A case study

The biologics development and approval process for pharmaceutical companies around the world is typically long and complex, which increases the risk of inaccurately forecasting demand

Dealing with biologics production uncertainty

Serialization’s interface between the plant floor, the enterprise and the world

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis

Opinion